2014
DOI: 10.3341/kjo.2014.28.6.460
|View full text |Cite
|
Sign up to set email alerts
|

Elevated Plasma Pentraxin 3 and Its Association with Retinal Vein Occlusion

Abstract: PurposeTo evaluate plasma pentraxin 3 (PTX3) in patients with retinal vein occlusion (RVO), and investigate the possibility of its role as a predictive biomarker.MethodsNested case-control study. The study included 57 patients with RVO and 45 age- and gender-matched subjects without RVO as controls. Plasma PTX3 and C-reactive protein concentration were measured in both groups a posteriori from frozen samples by using an enzyme-linked immunosorbent assay kit.ResultsThe measured PTX3 value for the RVO group was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 32 publications
(35 reference statements)
0
6
0
Order By: Relevance
“…Therefore, the level of PTX3 may be more directly responsive to the inflammatory state. 32,34 Previous studies found that PTX3 participates in inflammatory, regulates the distribution of white blood cells and improves the permeability of blood vessels by binding to different ligands such as growth factors, extracellular matrix components, complement cascade molecules, pathogen recognition proteins, angiogenesis and adhesion molecules. 35 In addition, it was reported that PTX3 can inhibit growth and invasion of tumor cells by blocking Akt and NF-κB signaling pathway, but the mechanism was still unclear.…”
Section: Physiological Functions and Mechanisms Of Tnfaip5mentioning
confidence: 99%
“…Therefore, the level of PTX3 may be more directly responsive to the inflammatory state. 32,34 Previous studies found that PTX3 participates in inflammatory, regulates the distribution of white blood cells and improves the permeability of blood vessels by binding to different ligands such as growth factors, extracellular matrix components, complement cascade molecules, pathogen recognition proteins, angiogenesis and adhesion molecules. 35 In addition, it was reported that PTX3 can inhibit growth and invasion of tumor cells by blocking Akt and NF-κB signaling pathway, but the mechanism was still unclear.…”
Section: Physiological Functions and Mechanisms Of Tnfaip5mentioning
confidence: 99%
“…PTX3 has been evaluated also in the retinal vein occlusion (RVO), the second most common retinal vascular disease after diabetic retinopathy. This study demonstrate that PTX3 could be used as a useful diagnostic biomarker since patients with RVO have high plasma level of PTX3 [ 70 ]. Finally, during 2016 Zhou and Hu suggest that the use of PTX3 could be used as an anti-angiogenic molecule because PTX3 interacts specifically with FGF2 factor reducing the proliferative diabetic retinopathy thus ameliorating DR condition [ 68 ].…”
Section: Ptx3 In Cardiovascular Diseasesmentioning
confidence: 99%
“…Furthermore, disorders such as deficiency of Protein C and S, deficiency of antithrombin III, or a genetic mutation in prothrombin gene, antiphospholipid antibodies and hyperhomocysteinemia are other possible pathophysiologic mechanisms of BRVO. 5 A multitude of risk factors have been considered in BRVOs, including diabetes mellitus, atherosclerotic disease, hypertension, open angle glaucoma, connective tissue pathologies, P J M H S Vol. 15, NO.9, SEP 2021 2365 thrombophilia and other causes of hyper-coagulability.…”
Section: Discussionmentioning
confidence: 99%